Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer Screening
Primary Purpose
Healthy Volunteers
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Decision aid with implicit values clarification method (booklet or website)
Decision aid with explicit values clarification method (booklet or website)
Sponsored by
About this trial
This is an interventional other trial for Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
- adult men (50 - 69 years);
- men with average risk for prostate cancer;
- willing and able to provide written informed consent.
Exclusion Criteria:
- unable to understand written Portuguese.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
No Intervention
Active Comparator
Active Comparator
Arm Label
decision aid with information only (control)
decision aid with implicit VCM
decision aid with explicit VCM
Arm Description
decision aid with information only, without values clarification method (VCM)
decision aid with information plus an implicit VCM
decision aid with information plus an explicit VCM
Outcomes
Primary Outcome Measures
Perceived clarity of personal values
3-item subscale of the Decisional Conflict Scale. Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 3; and c) multiplied by 25. Scores range from 0 [feels extremely clear about personal values] to 100 [feels extremely unclear about personal values].
Secondary Outcome Measures
Decisional Conflict
Decisional Conflict Scale (16-item). Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 16; and c) multiplied by 25. Scores range from 0 [no decisional conflict] to 100 [extremely high decisional conflict].
% of patients with preference to undergo PSA screening (screening intention; questionnaire)
Intention to undergo prostate cancer screening with PSA: questionnaire - single question about intention to be screened with PSA, using a 5 point-Likert scale (ranging from "strongly disagree" to "strongly agree"; intention to undergo PSA screening will be considered positive if the respondent replies with "agree" or "strongly agree"). % of patients with preference to undergo PSA screening.
% of patients who underwent PSA screening (questionnaire)
Self-reported PSA screening. Questionnaire - single question. Men will report wether they have or have not underwent PSA screening after the intervention. % of patients who underwent PSA screening
Full Information
NCT ID
NCT03988673
First Posted
June 3, 2019
Last Updated
June 14, 2019
Sponsor
Universidade do Porto
Collaborators
NOVA Medical School, Georgetown University
1. Study Identification
Unique Protocol Identification Number
NCT03988673
Brief Title
Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer Screening
Official Title
Comparison of Explicit Values Clarification Method (VCM), Implicit VCM and no VCM Decision Aids for Men Considering Prostate Cancer Screening: Protocol of a Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2019
Overall Recruitment Status
Unknown status
Study Start Date
September 2019 (Anticipated)
Primary Completion Date
December 2019 (Anticipated)
Study Completion Date
September 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Universidade do Porto
Collaborators
NOVA Medical School, Georgetown University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators aim at comparing the perceived clarity of personal values in men considering PSA screening using decision aids with no VCM versus an implicit VCM versus an explicit VCM. This study will add to the body of evidence on the role of decision aids to support health preference-sensitive choices and provide further insight on the impact of different methods for eliciting people's values embedded within a decision aid.
Detailed Description
PSA test to screen for prostate cancer is considered a preference sensitive decision, meaning it does not only depend on what is best from a medical point of view, but also on patient values. Decision aids are evidence-based tools which showed to help people feel clearer about their values, therefore it has been advocated that decision aids should contain a specific values clarification method (VCM). VCM may be either implicit or explicit but the evidence concerning the best method is scarce. We aim at comparing the perceived clarity of personal values in men considering PSA screening using decision aids with no VCM versus an implicit VCM versus an explicit VCM.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy Volunteers
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Parallel three group (1:1:1): (i) decision aid with information only (Control), (ii) decision aid with information plus an implicit VCM, (iii) decision aid with information plus an explicit VCM.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
276 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
decision aid with information only (control)
Arm Type
No Intervention
Arm Description
decision aid with information only, without values clarification method (VCM)
Arm Title
decision aid with implicit VCM
Arm Type
Active Comparator
Arm Description
decision aid with information plus an implicit VCM
Arm Title
decision aid with explicit VCM
Arm Type
Active Comparator
Arm Description
decision aid with information plus an explicit VCM
Intervention Type
Other
Intervention Name(s)
Decision aid with implicit values clarification method (booklet or website)
Intervention Description
The intervention will be an informative evidence-based material in the format of a booklet or website concerning prostate cancer screening. The values clarification method will be a grid where statements about the subject will be presented (decision aid with implicit VCM).
Intervention Type
Other
Intervention Name(s)
Decision aid with explicit values clarification method (booklet or website)
Intervention Description
The intervention will be an informative evidence-based material in the format of a booklet or website concerning prostate cancer screening. The values clarification method will be a a grid where statements about the subject will be presented and men should indicate what statements they identify with (decision aid with explicit VCM).
Primary Outcome Measure Information:
Title
Perceived clarity of personal values
Description
3-item subscale of the Decisional Conflict Scale. Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 3; and c) multiplied by 25. Scores range from 0 [feels extremely clear about personal values] to 100 [feels extremely unclear about personal values].
Time Frame
immediately after the intervention
Secondary Outcome Measure Information:
Title
Decisional Conflict
Description
Decisional Conflict Scale (16-item). Items are given a score of 0 ("strongly agree") to 4 ("strongly disagree"). Items are: a) summed; b) divided 16; and c) multiplied by 25. Scores range from 0 [no decisional conflict] to 100 [extremely high decisional conflict].
Time Frame
immediately after the intervention
Title
% of patients with preference to undergo PSA screening (screening intention; questionnaire)
Description
Intention to undergo prostate cancer screening with PSA: questionnaire - single question about intention to be screened with PSA, using a 5 point-Likert scale (ranging from "strongly disagree" to "strongly agree"; intention to undergo PSA screening will be considered positive if the respondent replies with "agree" or "strongly agree"). % of patients with preference to undergo PSA screening.
Time Frame
before and immediately after the intervention
Title
% of patients who underwent PSA screening (questionnaire)
Description
Self-reported PSA screening. Questionnaire - single question. Men will report wether they have or have not underwent PSA screening after the intervention. % of patients who underwent PSA screening
Time Frame
6 months after the intervention
10. Eligibility
Sex
Male
Gender Based
Yes
Gender Eligibility Description
the intervention's purpose is to support men's prostate cancer screening decision
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
69 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
adult men (50 - 69 years);
men with average risk for prostate cancer;
willing and able to provide written informed consent.
Exclusion Criteria:
unable to understand written Portuguese.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sofia Baptista, MD
Phone
00351910357362
Email
sofiatbaptista@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
António Soares, PhD
Phone
00351225513622
Email
ajasoares@cintesis.eu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sofia Baptista, MD
Organizational Affiliation
Universidade do Porto
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Data will be made available on request
Citations:
PubMed Identifier
32349746
Citation
Baptista S, Heleno B, Teixeira A, Taylor KL, Martins C. Comparison of explicit values clarification method (VCM), implicit VCM and no VCM decision aids for men considering prostate cancer screening: protocol of a randomized trial. BMC Med Inform Decis Mak. 2020 Apr 29;20(1):78. doi: 10.1186/s12911-020-1094-3.
Results Reference
derived
Learn more about this trial
Comparison of Explicit, Implicit and no Values Clarification Decision Aids for Men Considering Prostate Cancer Screening
We'll reach out to this number within 24 hrs